SU-E-T-166: Clinical Impact of Minor Errors Discovered in Conventional IMRT QA On Patient Treatment

2013 ◽  
Vol 40 (6Part13) ◽  
pp. 242-242
Author(s):  
S Chang ◽  
M Lawrence ◽  
T Cullip ◽  
S Wang ◽  
D Fried
Keyword(s):  
Clinical Impact ◽  
Patient Treatment ◽  
Imrt Qa

Pacing for bradycardia: device features and algorithms and clinical impact

ESC CardioMed ◽  
2018 ◽  
pp. 1984-1988
Author(s):  
Jens Cosedis Nielsen ◽  
Jens Kristensen
Keyword(s):  
Cardiac Pacing ◽  
Optimal Choice ◽  
Clinical Impact ◽  
Patient Treatment ◽  
Pacing Mode ◽  
Device Programming

Cardiac pacing is the treatment of choice for patients with bradycardia. Several existing algorithms and features facilitate individualization and optimization of device programming on an individual patient basis. Individually based optimal choice of device and pacing mode should be the rule. Correct programming of available pacemaker algorithms and features is a prerequisite for optimal patient treatment.

scholarly journals PO-0786: Retrospective assessment of the clinical impact of errors detected in patient specific IMRT QA: a validation study

2013 ◽  
Vol 106 ◽  
pp. S300
Author(s):  
M.R. Malisan ◽  
L. Spadaccini ◽  
E. Moretti ◽  
A. Negri ◽  
C. Foti ◽  
...  
Keyword(s):  
Validation Study ◽  
Clinical Impact ◽  
Patient Specific ◽  
Imrt Qa ◽  
Retrospective Assessment

SU-FF-T-62: Alternative IMRT QA Technique During Prostate Patient Treatment

2007 ◽  
Vol 34 (6Part8) ◽  
pp. 2415-2415
Author(s):  
M Xu ◽  
A Sethi ◽  
M Gao ◽  
Y Ke ◽  
I Rusu ◽  
...  
Keyword(s):  
Patient Treatment ◽  
Imrt Qa

SU-GG-T-195: On the Correlation of Conventional IMRT QA Metrics to Clinical Impact in Per-Patient Dose QA

2010 ◽  
Vol 37 (6Part18) ◽  
pp. 3229-3230 ◽  
Author(s):  
H Zhen ◽  
B Nelms ◽  
W Tome
Keyword(s):  
Clinical Impact ◽  
Patient Dose ◽  
Imrt Qa

scholarly journals Understanding the Impact of Resistance to Influenza Antivirals

2021 ◽  
Vol 34 (2) ◽  
Author(s):  
Edward C. Holmes ◽  
Aeron C. Hurt ◽  
Zuzana Dobbie ◽  
Barry Clinch ◽  
John S. Oxford ◽  
...  
Keyword(s):  
Health Care Systems ◽  
Antiviral Treatment ◽  
Acquired Resistance ◽  
Clinical Impact ◽  
Patient Treatment ◽  
Antiviral Resistance ◽  
Front Line ◽  
Significant Burden ◽  
Care Systems ◽  
The Impact

SUMMARY Influenza poses a significant burden on society and health care systems. Although antivirals are an integral tool in effective influenza management, the potential for the emergence of antiviral-resistant viruses can lead to uncertainty and hesitation among front-line prescribers and policy makers. Here, we provide an overview of influenza antiviral resistance in context, exploring the key concepts underlying its development and clinical impact. Due to the acute nature of influenza in immunocompetent patients, resistant viruses that develop during antiviral treatment of a single patient (“treatment-emergent resistance”) are usually cleared in a relatively short time, with no impact on future antiviral efficacy. In addition, although available data are limited by small numbers of patients, they show that antiviral treatment still provides clinical benefit to the patient within whom resistance emerges. In contrast, the sustained community transmission of resistant variants in the absence of treatment (“acquired resistance”) is of greater concern and can potentially render front-line antivirals ineffective. Importantly, however, resistant viruses are usually associated with reduced fitness such that their widespread transmission is relatively rare. Influenza antivirals are an essential part of effective influenza management due to their ability to reduce the risk of complications and death in infected patients. Although antiviral resistance should be taken seriously and requires continuous careful monitoring, it is not comparable to antibiotic resistance in bacteria, which can become permanent and widespread, with far-reaching medical consequences. The benefits of antiviral treatment far outweigh concerns of potential resistance, which in the vast majority of cases does not have a significant clinical impact.

Dental students' payment for patient treatment

1983 ◽  
Vol 47 (12) ◽  
pp. 774-776
Author(s):  
JF Gardiner ◽  
MM Lee ◽  
BJ Legett ◽  
T Kretchun ◽  
E Herschaft ◽  
...  
Keyword(s):  
Dental Students ◽  
Patient Treatment

829: PSA-Flare up in Docetaxel Therapy of Hormone-Refractory Prostate cancer (HRPCA): Incidence and Clinical Impact?

2005 ◽  
Vol 173 (4S) ◽  
pp. 225-225
Author(s):  
Peter Olbert ◽  
Andres J. Schrader ◽  
Axel Hegele ◽  
Zoltan Varga ◽  
Axel Heidenreich ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Impact ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document